Jean-Pierre Ayoub - Concepedia

Author

Jean-Pierre Ayoub

The University of Texas MD Anderson Cancer Center

Also Known As

Ayoub, Jean Pierre, J Ayoub, J P Ayoub, J. Ayoub, J.-P. Ayoub, J.P. Ayoub, JEAN‐PIERRE AYOUB, Jean-Pierre Ayoub, Jean-pierre Ayoub

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Centre Hospitalier de l’Université de Montréal AbbVie (United States)Moffitt Cancer Center Centre Eugène Marquis

About

Jean-Pierre Ayoub is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	868
2	Health Sciences	2	2	77
3	Immunology	2	2	35
4	Engineering	1	1	81
5	Endocrinology	1	1	39

Jean-Pierre Ayoub

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja, Journal of Clinical Oncology	2002	1.1K
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. Pierre Ruffiè, R. Feld, Salomon Minkin, Journal of Clinical Oncology Retrospective StudyAppropriate Stratification VariablesTumoral PathologyWeight LossMedicine	1989	371
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial Véronique Dièras, Hyo S. Han, Bella Kaufman, The Lancet Oncology Breast OncologyMedicinePharmacologyPathologyBreast Cancer	2020	306
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel Brian Leyland‐Jones, Karen A. Gelmon, Jean-Pierre Ayoub, Journal of Clinical Oncology	2003	295
Unknown primary tumors metastatic to liver. Jean-Pierre Ayoub, Kenneth R. Hess, M C Abbruzzese, Journal of Clinical Oncology	1998	85
Water requirements and remote arid areas: the need for small-scale desalination Jean-Pierre Ayoub, R. Alward Desalination Water AvailabilityEngineeringWater ResourcesArid AreasWater Management	1996	81
Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial David Miles, Svetislava J. Vukelja, Vladimir Moiseyenko, Clinical Breast Cancer Survival BenefitOncologyClinical TrialsTherapeutic ControversyPharmacotherapy	2004	54
Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy Penelope A. Bradbury, Donald G. Morris, Garth Nicholas, Lung Cancer Standard Salvage TherapyOncologyAdvanced Lung DiseaseClinical TrialsPathology	2018	53
Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status Jean-Pierre Ayoub, P Audet-Lapointe, Y Méthot, Gynecologic Oncology MedicineGynecologyMenstrual CycleEndometrial CancerEndocrinology	1988	39
Paclitaxel activity for the treatment of non‐Hodgkin's lymphoma: final report of a phase II trial ANAS YOUNES, Jean-Pierre Ayoub, Andreas H. Sarris, British Journal of Haematology	1997	35

Page 1